In silico investigation and structural characterization of virulent factor and a metallo peptidase present in Helicobacter pylori strain J99

Interdisciplinary Sciences – Computational Life Sciences

Volumn 4, Issue 4, 2012, Pages 302-309

  Vaidya, Megha ^a   Panchal, Hetalkumar ^a  

^a SARDAR PATEL UNIVERSITY   (India)

Author keywords

drug target; gastric cancer; genomics and proteomics; Helicobacter. pylori J99; metallo peptidase; subtractive study; VacA

Indexed keywords

HELICOBACTER; HELICOBACTER PYLORI;

BACTERIAL PROTEIN; LIGAND; METALLOPROTEINASE; VACA PROTEIN, HELICOBACTER PYLORI; VIRULENCE FACTOR;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER PROGRAM; COMPUTER SIMULATION; CONFORMATION; DRUG ANTAGONISM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; METABOLISM; MICROBIOLOGY; MITOCHONDRION; PATHOGENICITY; PROTEIN DATABASE; SPECIES DIFFERENCE; VALIDATION STUDY;

BACTERIAL PROTEINS; BINDING SITES; COMPUTER SIMULATION; DATABASES, PROTEIN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIGANDS; METALLOPROTEASES; MITOCHONDRIA; MODELS, MOLECULAR; MOLECULAR CONFORMATION; SOFTWARE; SPECIES SPECIFICITY; VIRULENCE FACTORS;

MLCS; MLOWN;

EID: 84879350365     PISSN: 19132751     EISSN: 18671462     Source Type: Journal    
DOI: 10.1007/s12539-012-0145-6     Document Type: Article

References (46)

1. Atherton, J. C., Cao, P., Peek, R. M., Tummuru, M. K., Blaser, M. J., Cover, T. L. 1995. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270, 17771-17777.
2. Bhasin, M., Garg, A., G. P. S. 2005. In silico identification of potential therapeutic targets in Clostridium botulinum. Int J Bioinform Res 2, 2010-2015.
3. Borén, T., Falk, P., Roth, K. A., Larson, G., Normark, S. 1993. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262, 1892-1895.
4. Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Papadopoulos, J., Bealer, K., Madden, T. L. 2009. Architecture and applications. BMC Bioinformatics 10, 421.
5. Castrignanò T., De Meo, P. D., Cozzetto, D., Talamo, I. G., Tramontano, A. 2006. The PMDB Protein Model Database. Nucl Acid Res 34, 306-309.
6. Correa, P., Piazuelo, M. B., Camargo, M. C. 2004. The future of gastric cancer prevention. Gastric Cancer 7, 9-16.
7. Covacci, A., Censini, S., Bugnoli, M., Petracca, R., Burroni, D., Macchia, G., Massone, A., Papini, E., Xiang, Z., Figura, N., Rappuoli, R. 1993. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 90, 5791-5795.
8. Cover, T. L., Blanke, S. R. 2005. Helicobacter pylori VacA, a paradigm for toxin multifuntionality. Nat Rev Microbiol 3, 320-332.
9. Cover, T. L., Tummuru, M. K., Cao, P., Thompson, S. A., Blaser, M. J. 1994. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 269, 10566-10573.
10. Czajkowsky, D. M., Iwamoto, H., Cover, T. L., Shao, Z. F. 1999. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH. Proc Natl Acad Sci USA 96, 2001-2006.
11. DeLano, W. L. 2002. The PyMOL Molecular Graphics System, DeLano Scientific LLC, San Carlos, USA.
12. Dutta, A., Singh, S. K., Ghosh, P., Mukherjee, R., Mitter, S., Bandyopadhyay, D. 2006. In silico identification of potential therapeutic targets in the human pathogen Helicobacter pylori. In silico Biology 6, 0005.
13. Everhart, J. E. 2000. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am 29, 559-578.
14. Friedrich, A., Ripp, R., Garnier, N., Bettler, E., Deléage, G., Poch, O., Moulinier, L. 2007. Blast sampling for structural and functional analyses. BMC Bioinformatics 8, 62.
15. Galperin, M. Y., Koonin, E. V. 1999. Searching for drug targets in microbial genomes. Curr Opin Biotechnol 10, 571-578.
16. Gerhard, M., Lehn, N., Neumayer, N., Borén, T., Rad, R., Schepp, W., Miehlke, S., Classen, M., Prinz, C. 1999. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 96, 12778-12783.
17. Guex, N., Peitsch, M. C. 1997. SWISS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modeling. Electrophoresis 18, 2714-2723.
18. Herrera, V., Parsonnet, J. 2009. Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect 15, 971-976.
19. Herszényi, L., Tulassay, Z. 2010. Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 14, 249-258.
20. Ilver, D., Arnqvist, A., Ogren, J., Frick, I. M., Dangeruta, K., Incecik, E. T., Berg, D. E., Covacci, A., Engstrand, L., Borén, T. 1998. Helicobacter pylori adhesion binding fucosylated histo-blood group antigens revealed by retagging. Science 279, 373-376.
21. Kim, B.-H., Cheng, H., Grishin, N. V., Hor, A. 2009. Web server to infer homology between proteins using sequence and structural similarity. Nucleic Acids Res 37, 532-538.
22. Laskowski, R. A., MacArthur, M. W., Moss, D. S., Thornton, J. M. 1993. PROCHECK: A program to check the stereo chemical quality of protein structures. J Appl Cryst 26, 283-291.
23. Lyskov, S., Gray, J. J. 2008. The Rosetta Dock server for local protein protein docking. Nucleic Acids Res 36, 233-238.
24. Montecucco, C., Rappuoli, R. 2001. Living dangerously how Helicobacter pylori survives in the human stomach. Nat Rev Mol Cell Biol 2, 457-466.
25. Nguyen, V. Q., Caprioli, R. M., Cover, T. L. 2001. Carboxy-terminal proteolytic processing of Helicobacter pylori vacuolating toxin. Infect Immun 69, 543-546.
26. Odenbreit, S., Puls, J., Sedlmaier, B., Gerland, E., Fischer, W., Hass, R. 2000. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287, 1497-1500.
27. Padilla, P. I., Wada, A., Yahiro, K., Kimura, M., Niidome, T., Aoyagi, H., Kumatori, A., Anami, M., Hayashi, T., Fujisawa, J., Saito, H., Moss, J., Hirayama, T. 2000. Morphologic differentiation of HL-60 cells is associated with appearance of RPTP beta and induction of Helicobacter pylori VacA sensitivity. J Biol Chem 275, 15200-15206.
28. Papini, E., de Bernard, M., Milia, E., Bugnoli, M., Zerial, M., Rappuoli, R., Montecucco, C. 1994. Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc Natl Acad Sci USA 91, 9720-9724.
29. Peek, R. M. Jr., Blaser, M. J. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2, 28-37.
30. Phadnis, S. H., Ilver, D., Janzon, L., Normark, S., Westblom, T. U. 1994. Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect Immun 62, 1557-1565.
31. Piedra, D., Lois, S., De La Cruz, X. 2008. Preservation of protein clefts in comparative models. BMC Struct Biol 8, 2.
32. Prinz, C., Schoniger, M., Rad, R., Becker, I., Keiditsch, E., Wagenpfeil, S., Classen, M., Rosch, T., Schepp, W., Gerhard, M. 2001. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res 61, 1903-1909.
33. Rawlings, N. D., Morton, F. R., Kok, C. Y., Kong, J., Barrett, A. J. 2008. MEROPS: The peptidase database. Nucl Acid Res 36, 320-325.
34. Reddy, E. H., Satpathy, G. R. 2009. Identification of potential targets and lead molecules for designing inhibitory drugs against Chlamydophila pneumonia. Online Journal of Bioinformatics 10, 14-28.
35. Sakharkar, K. R., Sakharkar, M. K., Chow, V. T. K. 2004. A novel genomics approach for the identification of drug targets in pathogens, with special reference to Pseudomonas aeruginosa. In silico Biol 4, 0028.
36. Sanga, S., Frieboes, H. B., Zheng, X., Gatenby, R., Bearer, E. L., Cristini, V. 2007. Predictive oncology multidisciplinary, multi-scale in silico modeling linking phenotype, morphology and growth. Neuroimage 37, 120-134.
37. Sarangi, A. N., Aggarwal, R., Rahman, Q., Trivedi, N. 2009. Subtractive genomics approach for in silico identification and characterization of novel drug targets in Neisseria Meningitides Serogroup B. J Comput Sci Syst Biol 2, 255-258.
38. Schmitt, W., Haas, R. 1994. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: Structural similarities with IgA protease type of exported protein. Mol Microbiol 12, 307-319.
39. Seto, K., Hayashi-Kuwabara, Y., Yoneta, T., Suda, H., Tamaki, H. 1998. Vacuolation induced by cytotoxin from Helicobacter pylori is mediated by EGF receptor in HeLa cells. FEBS Lett 431, 347-350.
40. Telford, J. L., Ghiara, P., Dell'Orco, M., Comanducci, M., Burroni, D., Bugnoli, M., Tecce, M. F., Censini, S., Covacci, A., Xiang, Z. 1994. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 179, 1653-1658.
41. Tummuru, M. K., Cover, T. L., Blaser, M. J. 1993. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production. Infect Immun 61, 1799-1809.
42. Wong, B. C., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E., Lai, K. C., Hu, W. H., Yuen, S. T., Leung, S. Y., Fong, D. Y., Ho, J., Ching, C. K., Chen, J. S. 2004. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291, 187-194.
43. Yahiro, K., Wada, A., Nakayama, M., Kimura, T., Ogushi, K., Niidome, T., Aoyagi, H., Yoshino, K., Yonezawa, K., Moss, J., Hirayama, T. 2003. Proteintyrosine phosphatase alpha, RPTP alpha, is a Helicobacter pylori VacA receptor. J Biol Chem 278, 19183-19189.
44. Zachairias, M. 2003. Protein-protein docking with a reduced protein model accounting for side-chain flexibility. Protein Sci 12, 1271-1282.
45. Zarrilli, R., Ricci, V., Romano, M. 1999. Molecular response of gastric epithelial cells to Helicobacter pyloriinduced cell damage. Cell Microbiol 1, 93-99.
46. Zhang, R., Ou, H. Y., Zhang, C. T. 2004. DEG: A database of essential genes. Nucl Acid Res 32, D271-D272.